12-Year-Old Baycol False Claims Suit Survives 3rd Round Of Dismissal

Mealey's (November 14, 2018, 9:39 AM EST) -- MINNEAPOLIS — A Minnesota federal judge on Oct. 16 denied another motion by Bayer Healthcare Pharmaceuticals Inc. to dismiss a 12-year-old whistleblower lawsuit about the alleged fraudulent marketing of the statin drug Baycol (United States, ex rel. Laurie Simpson v. Bayer Healthcare, et al., No. 08-5758, D. Minn., 2018 U.S. Dist. LEXIS 178751)....

Attached Documents

Related Sections